Celcuity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.

About CELC

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. 

CEO
Brian F. Sullivan
CEOBrian F. Sullivan
Employees
87
Employees87
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
2012
Founded2012
Employees
87
Employees87

CELC Key Statistics

Market cap
522.56M
Market cap522.56M
Price-Earnings ratio
-4.55
Price-Earnings ratio-4.55
Dividend yield
Dividend yield
Average volume
268.21K
Average volume268.21K
High today
$13.97
High today$13.97
Low today
$13.13
Low today$13.13
Open price
$13.13
Open price$13.13
Volume
137.29K
Volume137.29K
52 Week high
$19.77
52 Week high$19.77
52 Week low
$7.58
52 Week low$7.58

CELC News

TipRanks 5d
Promising Preliminary Data and Positive Outlook for Celcuity’s Gedatolisib in Cancer Trials

Analyst Oliver McCammon of LifeSci Capital maintained a Buy rating on Celcuity (CELC – Research Report), retaining the price target of $27.00. Don’t Miss TipRa...

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.